The name Bayer Schering Pharma has been consigned to the corporate dustbin as its parent group institutes a branding shake-up. …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

